We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Ending months of haggling between lawmakers, Congress passed an omnibus appropriations bill and COVID-19 relief package late Monday with a seven-day continuing resolution in place to keep the government funded at fiscal 2020 levels until the legislation is signed into law as expected. Read More
Decision Diagnostics falsely claimed that their nonexistent test would soon hit the market, leading to price surges and increased trading of the company’s stock, the SEC alleged. Read More
The World Health Organization has announced that its COVAX program has now reached supply agreements for almost 2 billion doses of several promising COVID-19 vaccine candidates for distribution to less well-off countries next year. Read More
Oxford University released new trial data last week that raises further questions about the most effective dosing regimen for Oxford’s COVID-19 vaccine candidate, AZD1222, that is being co-developed with AstraZeneca and how it came to pass that two different dosing regimens were pursued. Read More
The House and Senate are expected to vote today on a combined fiscal 2021 appropriations and COVID-19 relief legislative package after passing another stopgap spending bill Sunday to keep the federal government funded for 24 hours. Read More
The FDA has announced that it is investigating multiple reports of allergic reactions to Pfizer/BioNTech’s COVID-19 vaccine as supplies of the shot continue to roll out across the U.S. this week. Read More
The U.S. is set to begin vaccinations of healthcare workers and long-term care facility residents with the nation’s second authorized COVID-19 vaccine today, following the landmark authorization Friday of Moderna’s highly effective shot and its subsequent rollout over the weekend. Read More
The European Commission last week exercised its option with Pfizer/BioNTech for an extra 100 million vaccine doses, for a total of 300 million — enough to vaccinate one third of the EU’s population. Read More
The company will now launch the test in Europe for use in healthcare settings, including clinics and emergency rooms, and will initiate trials evaluating its over-the-counter use. Read More
With COVID-19 cases surging across Europe, EC President Ursula von der Leyen announced yesterday that EU countries will start vaccinations with the two-dose Pfizer/BioNTech vaccine on Dec. 27. Read More